FDA approved for specific uses
Semaglutide
A GLP-1 medicine with FDA-approved products for type 2 diabetes and chronic weight management.
Strong human evidence for approved uses
Read fact sheet The fact sheet library
Peptide fact sheets, without the mystery fog.
Search by name, alias, category, approval status, or evidence level. Each fact sheet puts the quick answer and the unknowns up front.
Filter the library
Showing 10 of 10 fact sheets
FDA approved for specific uses
Tirzepatide
A dual GIP/GLP-1 receptor agonist approved for specific metabolic and sleep-apnea uses.
Strong human evidence for approved uses
Read fact sheet In clinical trials
Retatrutide
An investigational triple-receptor agonist in Phase 3 clinical trials.
Early human evidence
Read fact sheet FDA approved for specific uses
Liraglutide
An established GLP-1 medicine approved for specific diabetes and weight-management uses.
Strong human evidence for approved uses
Read fact sheet FDA approved for specific uses
Tesamorelin
A growth hormone-releasing factor analog approved for a narrow HIV-related indication.
Strong human evidence for approved uses
Read fact sheet Discontinued
Sermorelin
A growth hormone-releasing hormone analog whose former FDA-approved product was discontinued.
Limited or unclear evidence
Read fact sheet Not FDA approved
CJC-1295
An unapproved growth hormone-releasing hormone analog with limited human data.
Early human evidence
Read fact sheet Not FDA approved
Ipamorelin
An unapproved growth hormone secretagogue with limited clinical evidence and FDA-identified concerns.
Early human evidence
Read fact sheet Not FDA approved
BPC-157
An experimental synthetic peptide popular online despite very limited reliable human evidence.
Mostly animal or lab research
Read fact sheet Not FDA approved
Thymosin beta-4
A naturally occurring peptide studied in tissue repair; marketed fragments are not FDA approved.
Mostly animal or lab research
Read fact sheet